Forty-two–week safety study of topical nanoemulsion (NB-002) for the treatment of mild to moderate distal subungual onychomycosis: A randomized, double-blind, vehicle-controlled trial

P2112

  • Ijzerman, Marian PhD
  • Baker, James Jr MD
  • Flack, Mary MD
  • Robinson, Paula MS

  • 1NanoBio, Ann Arbor, MI, United States

    2NanoBio, Ann Arbor, MI, United States

    3NanoBio, Ann Arbor, MI, United States

    4NanoBio, Ann Arbor, MI, United States

Commercial support: NanoBio.

Journal of the American Academy of Dermatology 62(3):p AB77, March 2010.
Copyright © 2010 by Mosby, Inc.